CID 3013615

Cholan-24-amide, n-[3-[[(3.alpha.,5.beta.,7.alpha.,12.alpha.)-24-oxo-3,7,12-tris(sulfooxy)cholan-24-yl][4-[[(3.alpha.,5 .beta.7.alpha.12.alpha.-24-oxo-3,7,12-tris(sulfooxy)cholan-24-yl]amino]butyl]amino]propyl]-3,7,12-tris(sulfooxy)-, (3.alpha.5 .beta.,7.alpha.12.alpha.)-

Structural Information

Molecular Formula
C79H133N3O39S9
SMILES
C[C@H](CCC(=O)NCCCCN(CCCNC(=O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)OS(=O)(=O)O)C)OS(=O)(=O)O)OS(=O)(=O)O)C)C(=O)CC[C@@H](C)[C@H]5CC[C@@H]6[C@@]5([C@H](C[C@H]7[C@H]6[C@@H](C[C@H]8[C@@]7(CC[C@H](C8)OS(=O)(=O)O)C)OS(=O)(=O)O)OS(=O)(=O)O)C)[C@H]9CC[C@@H]1[C@@]9([C@H](C[C@H]2[C@H]1[C@@H](C[C@H]1[C@@]2(CC[C@H](C1)OS(=O)(=O)O)C)OS(=O)(=O)O)OS(=O)(=O)O)C
InChI
InChI=1S/C79H133N3O39S9/c1-44(53-16-19-56-71-59(41-65(77(53,56)7)119-128(104,105)106)74(4)28-25-50(113-122(86,87)88)35-47(74)38-62(71)116-125(95,96)97)13-22-68(83)80-31-10-11-33-82(70(85)24-15-46(3)55-18-21-58-73-61(43-67(79(55,58)9)121-130(110,111)112)76(6)30-27-52(115-124(92,93)94)37-49(76)40-64(73)118-127(101,102)103)34-12-32-81-69(84)23-14-45(2)54-17-20-57-72-60(42-66(78(54,57)8)120-129(107,108)109)75(5)29-26-51(114-123(89,90)91)36-48(75)39-63(72)117-126(98,99)100/h44-67,71-73H,10-43H2,1-9H3,(H,80,83)(H,81,84)(H,86,87,88)(H,89,90,91)(H,92,93,94)(H,95,96,97)(H,98,99,100)(H,101,102,103)(H,104,105,106)(H,107,108,109)(H,110,111,112)/t44-,45-,46-,47+,48+,49+,50-,51-,52-,53-,54-,55-,56+,57+,58+,59+,60+,61+,62-,63-,64-,65+,66+,67+,71+,72+,73+,74+,75+,76+,77-,78-,79-/m1/s1
InChIKey
NVZZUNALMKHFDR-QTUMUCGOSA-N
Compound name
[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-[(2R)-5-[4-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,7,12-trisulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]butyl-[3-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,7,12-trisulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]amino]-5-oxopentan-2-yl]-10,13-dimethyl-3,7-disulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] hydrogen sulfate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2035.6002 Da
Monoisotopic Mass

7.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2036.6075 301.4
[M+Na]+ 2058.5894 308.7
[M-H]- 2034.5929 307.9
[M+NH4]+ 2053.6340 305.6
[M+K]+ 2074.5634 302.3
[M+H-H2O]+ 2018.5975 298.7
[M+HCOO]- 2080.5984 305.7
[M+CH3COO]- 2094.6141 306.5
[M+Na-2H]- 2056.5749 320.8
[M]+ 2035.5997 313.2
[M]- 2035.6007 313.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.